These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17634686)

  • 1. Malignant mesothelioma: global incidence and relationship with asbestos.
    Bianchi C; Bianchi T
    Ind Health; 2007 Jun; 45(3):379-87. PubMed ID: 17634686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SENTIERI - Epidemiological study of residents in national priority contaminated sites: incidence of mesothelioma].
    GdL SENTIERI-ReNaM
    Epidemiol Prev; 2016; 40(5Suppl1):1-116. PubMed ID: 27825195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade of malignant mesothelioma surveillance in Korea.
    Jung SH; Kim HR; Koh SB; Yong SJ; Chung MJ; Lee CH; Han J; Eom MS; Oh SS
    Am J Ind Med; 2012 Oct; 55(10):869-75. PubMed ID: 22544626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register.
    Marinaccio A; Binazzi A; Cauzillo G; Cavone D; Zotti RD; Ferrante P; Gennaro V; Gorini G; Menegozzo M; Mensi C; Merler E; Mirabelli D; Montanaro F; Musti M; Pannelli F; Romanelli A; Scarselli A; Tumino R;
    Eur J Cancer; 2007 Dec; 43(18):2722-8. PubMed ID: 17980576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates.
    Goldberg S; Rey G; Luce D; Gilg Soit Ilg A; Rolland P; Brochard P; Imbernon E; Goldberg M
    Occup Environ Med; 2010 Jun; 67(6):417-21. PubMed ID: 20522822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asbestos-related occupational cancers compensated under the Industrial Accident Compensation Insurance in Korea.
    Ahn YS; Kang SK
    Ind Health; 2009 Apr; 47(2):113-22. PubMed ID: 19367039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region.
    Girardi P; Bressan V; Merler E
    Cancer Epidemiol; 2014 Oct; 38(5):496-503. PubMed ID: 25200195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asbestos Exposure and the Mesothelioma Incidence in Poland.
    Krówczyńska M; Wilk E
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30104558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma in parts of Japan in relationship to asbestos exposure.
    Kishimoto T; Ozaki S; Kato K; Nishi H; Genba K
    Ind Health; 2004 Oct; 42(4):435-9. PubMed ID: 15540627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mesothelioma in Australia 2015: Current incidence and asbestos exposure trends.
    Soeberg MJ; Leigh J; van Zandwijk N
    J Toxicol Environ Health B Crit Rev; 2016; 19(5-6):173-189. PubMed ID: 27705544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of mesothelioma cases in different occupational groups and industries in Australia, 1979-1995.
    Yeung P; Rogers A; Johnson A
    Appl Occup Environ Hyg; 1999 Nov; 14(11):759-67. PubMed ID: 10590549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mesothelioma.
    Kao SC; Reid G; Lee K; Vardy J; Clarke S; van Zandwijk N
    Intern Med J; 2010 Nov; 40(11):742-50. PubMed ID: 20298508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descriptive epidemiology of malignant mesothelioma.
    Bertazzi PA
    Med Lav; 2005; 96(4):287-303. PubMed ID: 16457426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuscany mesothelioma registry (1988-2000): evaluation of asbestos exposure].
    Gorini G; Silvestri S; Merler E; Chellini E; Cacciarini V; Seniori Costantini AS
    Med Lav; 2002; 93(6):507-18. PubMed ID: 12596421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States.
    Lemen RA
    J Toxicol Environ Health B Crit Rev; 2016; 19(5-6):250-265. PubMed ID: 27705549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
    Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latency periods in asbestos-related mesothelioma of the pleura.
    Bianchi C; Giarelli L; Grandi G; Brollo A; Ramani L; Zuch C
    Eur J Cancer Prev; 1997 Apr; 6(2):162-6. PubMed ID: 9237066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asbestos exposure and mesothelioma incidence and mortality in Bulgaria.
    Vangelova K; Dimitrova I
    Rev Environ Health; 2016 Jun; 31(2):203-9. PubMed ID: 27180335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register.
    Marinaccio A; Binazzi A; Marzio DD; Scarselli A; Verardo M; Mirabelli D; Gennaro V; Mensi C; Riboldi L; Merler E; Zotti RD; Romanelli A; Chellini E; Silvestri S; Pascucci C; Romeo E; Menegozzo S; Musti M; Cavone D; Cauzillo G; Tumino R; Nicita C; Melis M; Iavicoli S;
    Int J Cancer; 2012 May; 130(9):2146-54. PubMed ID: 21647880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.